Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Maia Biotechnology, Inc.

NYSE: MAIA · Life Sciences · 4 alerts · CIK 1878313

Share price
$1.01Close, Nov 16
Market cap
$62.4M
Shares outstanding
61.75MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Maia Biotechnology, Inc. filings on SEC EDGAR ↗

9:01 AM ET 8-K
Clinical Trial Data

Maia Biotechnology Clinical Trial Data

MAIA Biotechnology reported updated interim efficacy data from Part C of its Phase 2 THIO-101 expansion trial evaluating ateganosine (THIO) in patients with advanced non-small cell lung cancer (NSCLC). The trial demonstrated an 88% disease control rate (DCR) in third-line patients who had progressed after prior immunotherapy and chemotherapy, significantly higher than the 25-35% DCR typically seen with standard chemotherapy.

5:07 PM ET 10-Q
Financial Results

Maia Biotechnology Q3 2026 Results: Net Loss of $7.18M, Loss Narrows

For the nine months ended September 30, 2026, MAIA Biotechnology reported a net loss of $21.5 million, driven by $23.3 million in operating expenses. The company significantly strengthened its cash position to $21.3 million, up from $8.7 million at year-end 2025, primarily through a public offering that raised approximately $31.0 million.

Key figure
Net loss $7.18M
8:16 AM ET 8-K
Investor Presentation

Maia Biotechnology Investor Presentation

MAIA Biotechnology, Inc. has prepared and posted a new corporate investor presentation and a summary highlighting its operations and performance to its website. Management intends to use these materials for upcoming presentations to investors and analysts starting October 6, 2026.

9:04 AM ET Form 4
Insider Buying

Maia Biotechnology Insider Ramiro Guerrero Buys $49.5K of Stock

Ramiro Guerrero bought 37,595 shares of Maia Biotechnology, Inc. at $1.32 a share, worth $49.5K in total on Sep 10, 2026. Shares held after the trade: 773,296 (+5.1%).

Value
$49.5K
Shares
37,595
Price
$1.32
Holding change
+5.1%
Trade date
Sep 10, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.